Fundamental Data for AGIX

ATHEROGENI(NSDQ:AGIX)

AtheroGenics is an emerging pharmaceutical company focused on thediscovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as asthma. The company has designed its lead product candidate, AGI-1067, as an oral drug to benefit patients with coronary artery disease. The company has combined its basic research in the role of blood vessels in inflammation with applied research techniques into an integrated process to discover new drugs for treating diseases of chronic inflammation.

# Employees: 57

Address: 8995 Westside Parkway,Alpharetta,GA,USA

Phone: 678 336-2500

Fax: 678 336-2501

Website: www.atherogenics.com

Email: investor@atherogenics.com

Sector: Medical

Industry: MED-DRUGS

Executive Officers

Russell M. Medford (Presi.; C.E.O.; Dir.)

Mark P. Colonnese (Exec. V.P. Commercial Oper.; C.F.O.)

Charles A. Deignan (V.P. Fin. & Admn. & Princ. Acctg. Off.)

David Bearman (Dir.)

Vaughn D. Bryson (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 6/30/2008

Next Earnings Date(Expected): 10/23/2008

Mean EPS (Next Qtr): ($0.20)

Mean EPS (Year): ($1.30)

Mean Estimate(Long Term): ($0.01)

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 2

Shares Performance

Period	AGIX	Compare to S&P
YTD	-81.58 %	-67.77 %
4 Weeks	-82.05 %	-78.66 %
12 Weeks	-89.06 %	-86.26 %

Shares Information

Analyst Coverage: Y

Avg Volume: 1084804

Shares Outstanding: 39M

Market Cap: $0.00B

52 Week High: $1.86

52 Week Low: $0.07

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 1/1/1990 AGIX split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: 5.26 %

EPS Growth in Last Year: -125.00 %

Sales Growth in Last Quarter: -0.01 %

Sales Growth in Last Quarter: -100.00 %

Financials

Qtr Book Value: ($0.01)

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: -0.010